aluates Reports

$ 0.0

Automative

Global Drug Closed System Transmission Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-16Z8068

Global Drug Closed System Transmission Market Insights Forecast to 2028

BUY CHAPTERS

Global Drug Closed System Transmission Market Research Report 2025

Code: QYRE-Auto-16Z8068

Report

July 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Equashield

BD Medical

Teva Medical

ICU Medical

Corvida Medical

B. Braun

Yukon Medical

JMS North America

Carmel Pharma

Tevadaptor

ChemoLock

Drug Closed System Transmission Market Size

The global market for Drug Closed System Transmission was valued at US$ 1410 million in the year 2024 and is projected to reach a revised size of US$ 2067 million by 2031, growing at a CAGR of 5.7% during the forecast period.

Drug Closed System Transmission Market

Closed System Transfer Devices (CSTDs) are specialized medical devices designed to provide a closed and secure system for the handling, preparation, administration, and disposal of hazardous drugs, particularly in settings such as hospitals, pharmacies, and clinics. These devices are engineered to minimize the risk of exposure to hazardous medications for healthcare workers, patients, and the environment.

The Drug Closed System Transmission market focuses on providing specialized devices and solutions for the safe handling and administration of hazardous drugs in healthcare settings. These devices are designed to minimize the risk of exposure to hazardous medications for healthcare workers, patients, and the environment.

The global Drug Closed System Transmission market has been witnessing growth driven by increasing awareness about the risks associated with handling hazardous drugs, stringent regulations for occupational safety, and the growing adoption of closed system transfer devices in healthcare facilities.

Factors contributing to the growth of the global Drug Closed System Transmission market may include:

Implementation of Occupational Safety Standards: Regulatory bodies and healthcare organizations are increasingly recognizing the importance of protecting healthcare workers from exposure to hazardous drugs, leading to the adoption of stricter safety standards and guidelines.

Growing Focus on Patient Safety: Healthcare facilities are prioritizing patient safety by implementing closed system transfer devices to minimize the risks associated with the administration of hazardous medications.

Increasing Incidence of Cancer and Other Chronic Diseases: The rising prevalence of cancer and chronic diseases necessitates the safe handling and administration of chemotherapy drugs and other hazardous medications, thereby driving the demand for closed system transfer devices.

Technological Advancements: Continuous advancements in closed system transfer devices, such as improved compatibility with various medical components and enhanced performance, contribute to market growth.

Market Players and Competition: Several companies are actively involved in the development and supply of closed system transfer devices, resulting in increased competition and a wider range of options for healthcare facilities.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Closed System Transmission, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Closed System Transmission.

The Drug Closed System Transmission market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Closed System Transmission market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Closed System Transmission manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug Closed System Transmission Market Report

Report Metric	Details
Report Name	Drug Closed System Transmission Market
Accounted market size in year	US$ 1410 million
Forecasted market size in 2031	US$ 2067 million
CAGR	5.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Closed Vial Access Device Closed Syringe Safety Device Closed Bag/Line Access Device
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Equashield, BD Medical, Teva Medical, ICU Medical, Corvida Medical, B. Braun, Carmel Pharma, Yukon Medical, JMS North America, Tevadaptor, ChemoLock
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Closed System Transmission manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Closed System Transmission in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Drug Closed System Transmission Market growing?

Ans: The Drug Closed System Transmission Market witnessing a CAGR of 5.7% during the forecast period 2025-2031.

What is the Drug Closed System Transmission Market size in 2031?

Ans: The Drug Closed System Transmission Market size in 2031 will be US$ 2067 million.

Who are the main players in the Drug Closed System Transmission Market report?

Ans: The main players in the Drug Closed System Transmission Market are Equashield, BD Medical, Teva Medical, ICU Medical, Corvida Medical, B. Braun, Carmel Pharma, Yukon Medical, JMS North America, Tevadaptor, ChemoLock

What are the Application segmentation covered in the Drug Closed System Transmission Market report?

Ans: The Applications covered in the Drug Closed System Transmission Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Drug Closed System Transmission Market report?

Ans: The Types covered in the Drug Closed System Transmission Market report are Closed Vial Access Device, Closed Syringe Safety Device, Closed Bag/Line Access Device

Recommended Reports

Drug Delivery Systems

Medical Transfer Equipment

Medication Packaging Systems

1 Drug Closed System Transmission Market Overview

1.1 Product Definition

1.2 Drug Closed System Transmission by Type

1.2.1 Global Drug Closed System Transmission Market Value Comparison by Type (2024 VS 2031)

1.2.2 Closed Vial Access Device

1.2.3 Closed Syringe Safety Device

1.2.4 Closed Bag/Line Access Device

1.3 Drug Closed System Transmission by Application

1.3.1 Global Drug Closed System Transmission Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Drug Closed System Transmission Market Size Estimates and Forecasts

1.4.1 Global Drug Closed System Transmission Revenue 2020-2031

1.4.2 Global Drug Closed System Transmission Sales 2020-2031

1.4.3 Global Drug Closed System Transmission Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Drug Closed System Transmission Market Competition by Manufacturers

2.1 Global Drug Closed System Transmission Sales Market Share by Manufacturers (2020-2025)

2.2 Global Drug Closed System Transmission Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Drug Closed System Transmission Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Drug Closed System Transmission, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Drug Closed System Transmission, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Drug Closed System Transmission, Product Type & Application

2.7 Global Key Manufacturers of Drug Closed System Transmission, Date of Enter into This Industry

2.8 Global Drug Closed System Transmission Market Competitive Situation and Trends

2.8.1 Global Drug Closed System Transmission Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Drug Closed System Transmission Players Market Share by Revenue

2.8.3 Global Drug Closed System Transmission Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Drug Closed System Transmission Market Scenario by Region

3.1 Global Drug Closed System Transmission Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Drug Closed System Transmission Sales by Region: 2020-2031

3.2.1 Global Drug Closed System Transmission Sales by Region: 2020-2025

3.2.2 Global Drug Closed System Transmission Sales by Region: 2026-2031

3.3 Global Drug Closed System Transmission Revenue by Region: 2020-2031

3.3.1 Global Drug Closed System Transmission Revenue by Region: 2020-2025

3.3.2 Global Drug Closed System Transmission Revenue by Region: 2026-2031

3.4 North America Drug Closed System Transmission Market Facts & Figures by Country

3.4.1 North America Drug Closed System Transmission Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Drug Closed System Transmission Sales by Country (2020-2031)

3.4.3 North America Drug Closed System Transmission Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Drug Closed System Transmission Market Facts & Figures by Country

3.5.1 Europe Drug Closed System Transmission Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Drug Closed System Transmission Sales by Country (2020-2031)

3.5.3 Europe Drug Closed System Transmission Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Drug Closed System Transmission Market Facts & Figures by Region

3.6.1 Asia Pacific Drug Closed System Transmission Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Drug Closed System Transmission Sales by Region (2020-2031)

3.6.3 Asia Pacific Drug Closed System Transmission Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Drug Closed System Transmission Market Facts & Figures by Country

3.7.1 Latin America Drug Closed System Transmission Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Drug Closed System Transmission Sales by Country (2020-2031)

3.7.3 Latin America Drug Closed System Transmission Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Drug Closed System Transmission Market Facts & Figures by Country

3.8.1 Middle East and Africa Drug Closed System Transmission Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Drug Closed System Transmission Sales by Country (2020-2031)

3.8.3 Middle East and Africa Drug Closed System Transmission Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Drug Closed System Transmission Sales by Type (2020-2031)

4.1.1 Global Drug Closed System Transmission Sales by Type (2020-2025)

4.1.2 Global Drug Closed System Transmission Sales by Type (2026-2031)

4.1.3 Global Drug Closed System Transmission Sales Market Share by Type (2020-2031)

4.2 Global Drug Closed System Transmission Revenue by Type (2020-2031)

4.2.1 Global Drug Closed System Transmission Revenue by Type (2020-2025)

4.2.2 Global Drug Closed System Transmission Revenue by Type (2026-2031)

4.2.3 Global Drug Closed System Transmission Revenue Market Share by Type (2020-2031)

4.3 Global Drug Closed System Transmission Price by Type (2020-2031)

5 Segment by Application

5.1 Global Drug Closed System Transmission Sales by Application (2020-2031)

5.1.1 Global Drug Closed System Transmission Sales by Application (2020-2025)

5.1.2 Global Drug Closed System Transmission Sales by Application (2026-2031)

5.1.3 Global Drug Closed System Transmission Sales Market Share by Application (2020-2031)

5.2 Global Drug Closed System Transmission Revenue by Application (2020-2031)

5.2.1 Global Drug Closed System Transmission Revenue by Application (2020-2025)

5.2.2 Global Drug Closed System Transmission Revenue by Application (2026-2031)

5.2.3 Global Drug Closed System Transmission Revenue Market Share by Application (2020-2031)

5.3 Global Drug Closed System Transmission Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Equashield

6.1.1 Equashield Company Information

6.1.2 Equashield Description and Business Overview

6.1.3 Equashield Drug Closed System Transmission Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Equashield Drug Closed System Transmission Product Portfolio

6.1.5 Equashield Recent Developments/Updates

6.2 BD Medical

6.2.1 BD Medical Company Information

6.2.2 BD Medical Description and Business Overview

6.2.3 BD Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2020-2025)

6.2.4 BD Medical Drug Closed System Transmission Product Portfolio

6.2.5 BD Medical Recent Developments/Updates

6.3 Teva Medical

6.3.1 Teva Medical Company Information

6.3.2 Teva Medical Description and Business Overview

6.3.3 Teva Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Teva Medical Drug Closed System Transmission Product Portfolio

6.3.5 Teva Medical Recent Developments/Updates

6.4 ICU Medical

6.4.1 ICU Medical Company Information

6.4.2 ICU Medical Description and Business Overview

6.4.3 ICU Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2020-2025)

6.4.4 ICU Medical Drug Closed System Transmission Product Portfolio

6.4.5 ICU Medical Recent Developments/Updates

6.5 Corvida Medical

6.5.1 Corvida Medical Company Information

6.5.2 Corvida Medical Description and Business Overview

6.5.3 Corvida Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Corvida Medical Drug Closed System Transmission Product Portfolio

6.5.5 Corvida Medical Recent Developments/Updates

6.6 B. Braun

6.6.1 B. Braun Company Information

6.6.2 B. Braun Description and Business Overview

6.6.3 B. Braun Drug Closed System Transmission Sales, Revenue and Gross Margin (2020-2025)

6.6.4 B. Braun Drug Closed System Transmission Product Portfolio

6.6.5 B. Braun Recent Developments/Updates

6.7 Carmel Pharma

6.7.1 Carmel Pharma Company Information

6.7.2 Carmel Pharma Description and Business Overview

6.7.3 Carmel Pharma Drug Closed System Transmission Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Carmel Pharma Drug Closed System Transmission Product Portfolio

6.7.5 Carmel Pharma Recent Developments/Updates

6.8 Yukon Medical

6.8.1 Yukon Medical Company Information

6.8.2 Yukon Medical Description and Business Overview

6.8.3 Yukon Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Yukon Medical Drug Closed System Transmission Product Portfolio

6.8.5 Yukon Medical Recent Developments/Updates

6.9 JMS North America

6.9.1 JMS North America Company Information

6.9.2 JMS North America Description and Business Overview

6.9.3 JMS North America Drug Closed System Transmission Sales, Revenue and Gross Margin (2020-2025)

6.9.4 JMS North America Drug Closed System Transmission Product Portfolio

6.9.5 JMS North America Recent Developments/Updates

6.10 Tevadaptor

6.10.1 Tevadaptor Company Information

6.10.2 Tevadaptor Description and Business Overview

6.10.3 Tevadaptor Drug Closed System Transmission Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Tevadaptor Drug Closed System Transmission Product Portfolio

6.10.5 Tevadaptor Recent Developments/Updates

6.11 ChemoLock

6.11.1 ChemoLock Company Information

6.11.2 ChemoLock Description and Business Overview

6.11.3 ChemoLock Drug Closed System Transmission Sales, Revenue and Gross Margin (2020-2025)

6.11.4 ChemoLock Drug Closed System Transmission Product Portfolio

6.11.5 ChemoLock Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Drug Closed System Transmission Industry Chain Analysis

7.2 Drug Closed System Transmission Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Drug Closed System Transmission Production Mode & Process Analysis

7.4 Drug Closed System Transmission Sales and Marketing

7.4.1 Drug Closed System Transmission Sales Channels

7.4.2 Drug Closed System Transmission Distributors

7.5 Drug Closed System Transmission Customer Analysis

8 Drug Closed System Transmission Market Dynamics

8.1 Drug Closed System Transmission Industry Trends

8.2 Drug Closed System Transmission Market Drivers

8.3 Drug Closed System Transmission Market Challenges

8.4 Drug Closed System Transmission Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Equashield

BD Medical

Teva Medical

ICU Medical

Corvida Medical

B. Braun

Yukon Medical

JMS North America

Carmel Pharma

Tevadaptor

ChemoLock

List of Tables

Table 1. Global Drug Closed System Transmission Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Drug Closed System Transmission Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Drug Closed System Transmission Market Competitive Situation by Manufacturers in 2024

Table 4. Global Drug Closed System Transmission Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Drug Closed System Transmission Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Drug Closed System Transmission Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Drug Closed System Transmission Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Drug Closed System Transmission Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Drug Closed System Transmission, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Drug Closed System Transmission, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Drug Closed System Transmission, Product Type & Application

Table 12. Global Key Manufacturers of Drug Closed System Transmission, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Drug Closed System Transmission by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Closed System Transmission as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Drug Closed System Transmission Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Drug Closed System Transmission Sales by Region (2020-2025) & (K Units)

Table 18. Global Drug Closed System Transmission Sales Market Share by Region (2020-2025)

Table 19. Global Drug Closed System Transmission Sales by Region (2026-2031) & (K Units)

Table 20. Global Drug Closed System Transmission Sales Market Share by Region (2026-2031)

Table 21. Global Drug Closed System Transmission Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Drug Closed System Transmission Revenue Market Share by Region (2020-2025)

Table 23. Global Drug Closed System Transmission Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Drug Closed System Transmission Revenue Market Share by Region (2026-2031)

Table 25. North America Drug Closed System Transmission Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Drug Closed System Transmission Sales by Country (2020-2025) & (K Units)

Table 27. North America Drug Closed System Transmission Sales by Country (2026-2031) & (K Units)

Table 28. North America Drug Closed System Transmission Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Drug Closed System Transmission Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Drug Closed System Transmission Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Drug Closed System Transmission Sales by Country (2020-2025) & (K Units)

Table 32. Europe Drug Closed System Transmission Sales by Country (2026-2031) & (K Units)

Table 33. Europe Drug Closed System Transmission Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Drug Closed System Transmission Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Drug Closed System Transmission Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Drug Closed System Transmission Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Drug Closed System Transmission Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Drug Closed System Transmission Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Drug Closed System Transmission Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Drug Closed System Transmission Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Drug Closed System Transmission Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Drug Closed System Transmission Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Drug Closed System Transmission Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Drug Closed System Transmission Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Drug Closed System Transmission Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Drug Closed System Transmission Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Drug Closed System Transmission Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Drug Closed System Transmission Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Drug Closed System Transmission Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Drug Closed System Transmission Sales (K Units) by Type (2020-2025)

Table 51. Global Drug Closed System Transmission Sales (K Units) by Type (2026-2031)

Table 52. Global Drug Closed System Transmission Sales Market Share by Type (2020-2025)

Table 53. Global Drug Closed System Transmission Sales Market Share by Type (2026-2031)

Table 54. Global Drug Closed System Transmission Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Drug Closed System Transmission Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Drug Closed System Transmission Revenue Market Share by Type (2020-2025)

Table 57. Global Drug Closed System Transmission Revenue Market Share by Type (2026-2031)

Table 58. Global Drug Closed System Transmission Price (US$/Unit) by Type (2020-2025)

Table 59. Global Drug Closed System Transmission Price (US$/Unit) by Type (2026-2031)

Table 60. Global Drug Closed System Transmission Sales (K Units) by Application (2020-2025)

Table 61. Global Drug Closed System Transmission Sales (K Units) by Application (2026-2031)

Table 62. Global Drug Closed System Transmission Sales Market Share by Application (2020-2025)

Table 63. Global Drug Closed System Transmission Sales Market Share by Application (2026-2031)

Table 64. Global Drug Closed System Transmission Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Drug Closed System Transmission Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Drug Closed System Transmission Revenue Market Share by Application (2020-2025)

Table 67. Global Drug Closed System Transmission Revenue Market Share by Application (2026-2031)

Table 68. Global Drug Closed System Transmission Price (US$/Unit) by Application (2020-2025)

Table 69. Global Drug Closed System Transmission Price (US$/Unit) by Application (2026-2031)

Table 70. Equashield Company Information

Table 71. Equashield Description and Business Overview

Table 72. Equashield Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Equashield Drug Closed System Transmission Product

Table 74. Equashield Recent Developments/Updates

Table 75. BD Medical Company Information

Table 76. BD Medical Description and Business Overview

Table 77. BD Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. BD Medical Drug Closed System Transmission Product

Table 79. BD Medical Recent Developments/Updates

Table 80. Teva Medical Company Information

Table 81. Teva Medical Description and Business Overview

Table 82. Teva Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Teva Medical Drug Closed System Transmission Product

Table 84. Teva Medical Recent Developments/Updates

Table 85. ICU Medical Company Information

Table 86. ICU Medical Description and Business Overview

Table 87. ICU Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. ICU Medical Drug Closed System Transmission Product

Table 89. ICU Medical Recent Developments/Updates

Table 90. Corvida Medical Company Information

Table 91. Corvida Medical Description and Business Overview

Table 92. Corvida Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Corvida Medical Drug Closed System Transmission Product

Table 94. Corvida Medical Recent Developments/Updates

Table 95. B. Braun Company Information

Table 96. B. Braun Description and Business Overview

Table 97. B. Braun Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. B. Braun Drug Closed System Transmission Product

Table 99. B. Braun Recent Developments/Updates

Table 100. Carmel Pharma Company Information

Table 101. Carmel Pharma Description and Business Overview

Table 102. Carmel Pharma Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Carmel Pharma Drug Closed System Transmission Product

Table 104. Carmel Pharma Recent Developments/Updates

Table 105. Yukon Medical Company Information

Table 106. Yukon Medical Description and Business Overview

Table 107. Yukon Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Yukon Medical Drug Closed System Transmission Product

Table 109. Yukon Medical Recent Developments/Updates

Table 110. JMS North America Company Information

Table 111. JMS North America Description and Business Overview

Table 112. JMS North America Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. JMS North America Drug Closed System Transmission Product

Table 114. JMS North America Recent Developments/Updates

Table 115. Tevadaptor Company Information

Table 116. Tevadaptor Description and Business Overview

Table 117. Tevadaptor Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Tevadaptor Drug Closed System Transmission Product

Table 119. Tevadaptor Recent Developments/Updates

Table 120. ChemoLock Company Information

Table 121. ChemoLock Description and Business Overview

Table 122. ChemoLock Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. ChemoLock Drug Closed System Transmission Product

Table 124. ChemoLock Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Drug Closed System Transmission Distributors List

Table 128. Drug Closed System Transmission Customers List

Table 129. Drug Closed System Transmission Market Trends

Table 130. Drug Closed System Transmission Market Drivers

Table 131. Drug Closed System Transmission Market Challenges

Table 132. Drug Closed System Transmission Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Drug Closed System Transmission

Figure 2. Global Drug Closed System Transmission Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drug Closed System Transmission Market Share by Type: 2024 & 2031

Figure 4. Closed Vial Access Device Product Picture

Figure 5. Closed Syringe Safety Device Product Picture

Figure 6. Closed Bag/Line Access Device Product Picture

Figure 7. Global Drug Closed System Transmission Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Drug Closed System Transmission Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Other

Figure 12. Global Drug Closed System Transmission Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Drug Closed System Transmission Market Size (2020-2031) & (US$ Million)

Figure 14. Global Drug Closed System Transmission Sales (2020-2031) & (K Units)

Figure 15. Global Drug Closed System Transmission Average Price (US$/Unit) & (2020-2031)

Figure 16. Drug Closed System Transmission Report Years Considered

Figure 17. Drug Closed System Transmission Sales Share by Manufacturers in 2024

Figure 18. Global Drug Closed System Transmission Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Drug Closed System Transmission Players: Market Share by Revenue in Drug Closed System Transmission in 2024

Figure 20. Drug Closed System Transmission Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Drug Closed System Transmission Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Drug Closed System Transmission Sales Market Share by Country (2020-2031)

Figure 23. North America Drug Closed System Transmission Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Drug Closed System Transmission Sales Market Share by Country (2020-2031)

Figure 27. Europe Drug Closed System Transmission Revenue Market Share by Country (2020-2031)

Figure 28. Germany Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Drug Closed System Transmission Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Drug Closed System Transmission Revenue Market Share by Region (2020-2031)

Figure 35. China Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Drug Closed System Transmission Sales Market Share by Country (2020-2031)

Figure 46. Latin America Drug Closed System Transmission Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Drug Closed System Transmission Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Drug Closed System Transmission Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Drug Closed System Transmission Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Drug Closed System Transmission by Type (2020-2031)

Figure 56. Global Revenue Market Share of Drug Closed System Transmission by Type (2020-2031)

Figure 57. Global Drug Closed System Transmission Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Drug Closed System Transmission by Application (2020-2031)

Figure 59. Global Revenue Market Share of Drug Closed System Transmission by Application (2020-2031)

Figure 60. Global Drug Closed System Transmission Price (US$/Unit) by Application (2020-2031)

Figure 61. Drug Closed System Transmission Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Closed Systems Drug Transfer Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hazardous Drugs Closed System Transfer Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Closed System for Drug Transfer Market Research Report 2024

Global Closed System Transmission Equipment Market Research Report 2024

Global Medical Aseptic Transfer System Market Research Report 2024

Global Closed Transition Transfer Switch Market Research Report 2024

Global Needle free Closed System Transfer Equipment Market Research Report 2025

Global Disposable Sterile Medicine Liquid Transfer Device Market Research Report 2024

Patient Transfer Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Transfer Durable Medical Equipment Market Research Report 2024

Wearable Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sterile Liquid Transfer Port Market Research Report 2024

Global Sterile Transfer Systems Market Research Report 2025

Global Patient Transfer Durable Medical Equipment Market Research Report 2024

Global CSSD Furniture Market Research Report 2024

Closed Liquid Medicine Transfer Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Delivery Catheter System Market Research Report 2024

Global Center Chemical Dispense System CDS Market Research Report 2025

Transseptal Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions